This announcement is a separate document:
和元生物：海通证券股份有限公司关于和元生物技术（上海）股份有限公司2024年半年度持续督导跟踪报告
Heyuan Biotech: Haitong Securities Co., Ltd.\'s 2024 Semi-Annual Continuous Supervision and Follow-up Report on Heyuan Biotechnology (Shanghai) Co., Ltd.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated